Quantitative analysis for Regencell Bioscience Holdings Limited Ordinary Shares (RGC) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). 26 signals analyzed (21 differentiated alt-data).
RGC stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-06 | $28.10 | $27.27 | $27.59 |
| 2026-05-18 | $29.60 | $27.28 | $27.79 |
| 2026-05-29 | $24.55 | $23.71 | $23.90 |
| 2026-06-10 | $21.00 | $19.50 | $20.45 |
| 2026-06-23 | $12.00 | $10.48 | $11.08 |
| 2026-07-06 | $6.63 | $5.60 | $5.61 |
| 2026-07-16 | $5.21 | $4.67 | $4.78 |
| 2026-07-28 | $6.08 | $5.33 | $5.97 |
| 2026-08-07 | $5.75 | $5.24 | $5.41 |
| 2026-08-19 | $6.14 | $5.42 | $5.81 |
| 2026-08-31 | $5.54 | $5.43 | $5.51 |
| 2026-09-11 | $5.84 | $5.55 | $5.64 |
How Regencell Bioscience Holdings Limited Ordinary Shares stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
RGC scores Unrated (50.0), resting on a single measured dimension: technicals at 3 out of 100. The remaining dimensions are unmeasured for this ticker rather than weak. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 3 |
StoQuant analyzes 26 signals (21 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Regencell Bioscience Holdings Limited Ordinary Shares (RGC): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/RGC"><img src="https://stoquant.com/badge/RGC.svg" alt="Regencell Bioscience Holdings Limited Ordinary Shares (RGC) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.